PLRX
Pliant Therapeutics, Inc.
$1.11
-0.01 (-0.89%)
At close · Jul 16
Market Cap
$70.61M
Shares
61,920,249
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.11
Open$1.13
Day$1.09–1.14
52W$1.08–1.95
Avg vol 30d570K
Short int2.6M · 4.2% float · 7.0d
Short vol47%
DataJun 2020–Jul 2026
Filing10-Q · May 11
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 11, 2026
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 16.7 · calm
Equity put/call 0.67
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−16%
below
Price vs 50-day avg
−5%
below
RSI (14)
44
neutral
MACD trend
Negative
52-week position
3%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−7%
trailing
6-month return
−15%
trailing
YTD return
−9%
this year
Relative strength
−24%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
4 of 90 funds reported for Jun 30 · net +67.8K sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
4.17% of float · ▼ -8.3% MoM · 7.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
90 holders — near 3-yr low, contrarian setup
Squeeze score
62
elevated · 0–100
Fundamentals
EPS growth
+30%
Y/Y
Free cash flow
$-128.7M
Balance sheet
$45.4M
net cash
Quant / Vol
risk profile
Volatility
56%
annualized · 1-yr
Max drawdown
−42%
past year
ATR
4.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−16%
Bearish
Price vs 50-day avg
−5%
Bearish
RSI (14)
44
Neutral
MACD trend
Negative
Bearish
52-week position
3%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
4 of 90 funds reported for Jun 30 · net +67.8K sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
4.17% of float · ▼ -8.3% MoM · 7.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
90 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
52-wk low $1
Now $1 · 3%
52-wk high $2
vs 200-day avg -16%
vs 50-day avg -5%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PLRX
this stock
Pliant Therapeutics, Inc.
|
$70.61M | -9.0% | — | — | 4.2% |
|
ONC
BeOne Medicines Ltd.
|
$458.76B | +4.5% | +22179.2% | 933.6 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$123.36B | +7.2% | +46.2% | 28.8 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$71.18B | -11.9% | +20.8% | 16.6 | 3.3% |
|
ARGX
Argenx SE
|
$53.68B | +2.0% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PLRX | -1.8% | -6.7% | -14.6% | -2.6% | -9.0% |
| SPY | -0.1% | +0.1% | +9.0% | +0.5% | +10.1% |
| vs SPY | -1.6% | -6.8% | -23.6% | -3.2% | -19.1% |